Literature DB >> 21718721

The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.

Kristin E Smith1, Mona Boules, Katrina Williams, Abdul H Fauq, Elliott Richelson.   

Abstract

NT69L is a neurotensin (NT)(8-13) analog that binds the two major NT receptors, NTS1 and NTS2, and elicits similar behavioral effects as endogenous NT. Tolerance develops rapidly to some, but not to all of NT69L's effects, and to date, little is known about the mechanisms responsible for this tolerance. The development of tolerance appears to be more prevalent in behavioral effects mediated by NTS1 than by those mediated by NTS2, including hypothermia and thermal analgesia. However, we hypothesize that both NTS1 and NTS2 have important roles in mediating the effects of NT69L. Here, we investigate the role of NTS2 on NT69L-mediated hypothermia and thermal analgesia with the use of NTS2 knock-out mice. We show that tolerance develops to NT69L-mediated hypothermia and thermal analgesia following sub-chronic treatment in wild-type (WT) mice, and that NTS2 is necessary for the development of that tolerance. Additionally, we suggest potential means by which NTS2 influences these NT69L-mediated behaviors.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21718721      PMCID: PMC3159772          DOI: 10.1016/j.bbr.2011.06.014

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  47 in total

1.  Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.

Authors:  C Jomphe; P-L Lemelin; H Okano; K Kobayashi; L-E Trudeau
Journal:  Eur J Neurosci       Date:  2006-11-20       Impact factor: 3.386

2.  NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.

Authors:  Amélie Perron; Nadder Sharif; Philippe Sarret; Thomas Stroh; Alain Beaudet
Journal:  Biochem Biophys Res Commun       Date:  2006-12-18       Impact factor: 3.575

3.  Time course of the hypothermic response to continuously administered neurotensin.

Authors:  Erik Popp; Andreas Schneider; Peter Vogel; Peter Teschendorf; Bernd W Böttiger
Journal:  Neuropeptides       Date:  2007-07-25       Impact factor: 3.286

4.  Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.

Authors:  W E Fantegrossi; M C H Ko; J H Woods; E Richelson
Journal:  Pharmacol Biochem Behav       Date:  2004-12-30       Impact factor: 3.533

5.  Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain.

Authors:  Rui Wang; Mona Boules; Elisa Gollatz; Katrina Williams; William Tiner; Elliott Richelson
Journal:  Brain Res Mol Brain Res       Date:  2005-07-29

6.  NT79: A novel neurotensin analog with selective behavioral effects.

Authors:  Mona Boules; Yanqi Liang; Siobhan Briody; Tomofumi Miura; Irfan Fauq; Alfredo Oliveros; Mina Wilson; Shaheen Khaniyev; Katrina Williams; Zhimin Li; Yanfei Qi; Michael Katovich; Elliott Richelson
Journal:  Brain Res       Date:  2009-10-27       Impact factor: 3.252

7.  Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.

Authors:  Jordan A Mechanic; Janette E Sutton; Amy E Berson; Xiaosu Wu; Joyce Kwan; Rudy Schreiber; Zhen Pang; Donald C Button
Journal:  Eur Neuropsychopharmacol       Date:  2009-02-14       Impact factor: 4.600

8.  NT69L, a novel analgesic, shows synergy with morphine.

Authors:  M Boules; A Shaw; Y Liang; D Barbut; E Richelson
Journal:  Brain Res       Date:  2009-08-03       Impact factor: 3.252

9.  Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model.

Authors:  Geneviève Roussy; Marc-André Dansereau; Louis Doré-Savard; Karine Belleville; Nicolas Beaudet; Elliott Richelson; Philippe Sarret
Journal:  J Neurochem       Date:  2007-12-25       Impact factor: 5.372

10.  The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.

Authors:  R L Secchi; E Sung; L R Hedley; D Button; R Schreiber
Journal:  Behav Brain Res       Date:  2009-04-01       Impact factor: 3.332

View more
  4 in total

1.  A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice.

Authors:  Ko-Eun Choi; Casey L Hall; Jin-Mei Sun; Ling Wei; Osama Mohamad; Thomas A Dix; Shan P Yu
Journal:  FASEB J       Date:  2012-03-29       Impact factor: 5.191

2.  Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity.

Authors:  Darren Opland; Amy Sutton; Hillary Woodworth; Juliette Brown; Raluca Bugescu; Adriana Garcia; Lyndsay Christensen; Christopher Rhodes; Martin Myers; Gina Leinninger
Journal:  Mol Metab       Date:  2013-08-07       Impact factor: 7.422

Review 3.  Drug-induced hypothermia in stroke models: does it always protect?

Authors:  Meijuan Zhang; Haiying Wang; Jinbing Zhao; Cong Chen; Rehana K Leak; Yun Xu; Peter Vosler; Jun Chen; Yanqin Gao; Feng Zhang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

4.  Diverse roles of neurotensin agonists in the central nervous system.

Authors:  Mona Boules; Zhimin Li; Kristin Smith; Paul Fredrickson; Elliott Richelson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-22       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.